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background: Survival in pediatric and adult patients with failing Fontan physiology undergoing orthotropic heart transplantation (OHT) has been 
reported to be 77% at one year and 70% at five years (Lamour 2009). There is a paucity of data on the outcomes of adult failing Fontan patients 
who undergo OHT. We reviewed the results of adult failing Fontan patients undergoing OHT at UCLA Medical Center over the past decade.
Demographics: Thirteen patients were identified of 744 OHT recipients. The ages ranged from 19-44 years with an average age of 30.4 years. Five 
patients were male. The age at the time of the Fontan palliation ranged from 3 to 22 (mean 10.1 years). Eight patients had a classic RA-PA Fontan, 
three patients had undergone previous Fontan conversion from RA-PA to lateral tunnel. Two patients had heterotaxy syndrome and one patient 
underwent concomitant OHT and liver transplant.
results: Thirteen patients were transplanted between 2002 and 2013; two of which were transplanted in 2013. Survival at 90 days (n=13) and 
one year (n=11) was 100%, survival at three years (n= 6) was 83%, and survival at five years (n=5) was 80%. The single mortality occurred at 33 
months after OHT from coronary artery vasculopathy.
conclusions: In this single center cohort, adult patients with failing Fontan physiology undergoing OHT have similar short, intermediate, and long-
term survival compared to non-congenital adult patients at our center. These encouraging results in a contemporary cohort of adults are in contrast 
to prior published reports of poor outcomes following OHT in failing Fontan patients.
